What is the physical appearance of the product?

The product appears as a liquid.

Horse Equine Ehrlichia Antigen Detection Test for Accurate Diagnosis

Name: Horse Equine Ehrlichia Antigen Detection Test for Accurate Diagnosis
Brand: Guangzhou Herun Bio-Pharm Co., Ltd.
SKU: 2166956085

Guangdong, ChinaGuangzhou Herun Bio-Pharm Co., Ltd.

Negotiable

1 mg

Product profile

Customization

Available

Type

Raw Material

Usage

Reagent Kits, Research

Model NO.

HG-19

Delivery Time

7-10 Days

Purity

96%

Application Platform

Elisa, Fla, Tubidity and Colloidal Gold

Appearance

Liquid

Transport Package

Bottle

Specification

1mg/bottle

Trademark

CHEMICOS

Origin

China

HS Code

3002130000

Production Capacity

500g/Year

Key features

High Purity Raw Material: Provides 96% purity antigen for accurate diagnostic testing results.

Versatile Application Platforms: Compatible with Elisa, Fla, Tubidity, and Colloidal Gold detection methods.

Flexible OEM/ODM Services: Supports custom manufacturing and branding for reagent kits and research.

Fast Delivery Time: Standard delivery within 7-10 days for efficient project turnaround.

Low Minimum Order Quantity: Accepts orders starting from just 1 piece for flexible purchasing.

Liquid Appearance Format: Supplied in liquid form for immediate use in various diagnostic assays.

Company profile

Exhibition ExperienceLow MOQCustomization from SamplesODM Services

Guangzhou Herun Bio-Pharm Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedExport Year: N/A CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤8.91h CertifiedTerms of Payment: T/T

AI-Powered supplier vetting

SummaryThe supplier operates across services, forestry, animal husbandry and fishery, medical research, and sales of specialized medical, optical, agricultural, and testing equipment. It provides 3D design, ODM, OEM, SDK, and multiple customization services. Documented procedures exist for supplier assessment, corrective and preventive actions, and complaint handling, but quality assurance and raw-material traceability statuses are unknown. The supplier reports no new products in the past year and no inventory, overseas warehouse, or overseas showroom capability. Financial records are indicated for 2021–2023, but the provided data does not disclose performance results. Its company description emphasizes diagnostic products, protein-expression technology, R&D investment, and collaboration with universities and institutions.

Supplier typeThe supplier is a diversified service and technology-oriented company covering agricultural, forestry, animal husbandry and fishery, medical research, and specialized instrument and medical-device sales. Its stated focus on diagnostic products and solutions for human and animal health further indicates a life-science and healthcare-related supplier profile.

After-Sales capabilityThe supplier has a clear, documented complaint-handling procedure with implementation records and documented service-capability assessment procedures. However, no specific response scope, service network, or after-sales performance information is provided.

R&D capabilityThe supplier provides ODM services, OEM services for well-known brands, an available SDK, 3D design, and multiple design-customization options. Its description also cites product-development technology platforms, R&D investment, experienced scientists, and university or institutional collaboration; however, it launched no new products during the past year.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, and full customization, along with 3D software design and ODM services. These statements provide direct evidence of broad product and design customization capability.